Analysts' Views on Establishment Labs Holdings Inc.'s Future Growth Shape up After Mixed Earnests Report.
The investors in Establishment Labs Holdings Inc.'s (NASDAQ:ESTA) will be rubbing their hands together with glee today, after the share price leapt 28% to US$42.87 in the week following its full-year results. It was a pretty bad result overall; while revenues were in line with expectations at US$166m, statutory losses exploded to US$3.00 per share. The company's future growth prospects are now being closely watched by investors and analysts alike.
- The mixed earnings report may have given investors some comfort that the company's growth trajectory is still intact, but it also raises questions about whether Establishment Labs Holdings can sustain its ambitious expansion plans in a competitive industry.
- Will the company be able to overcome the challenges posed by its high-percentage losses and maintain its position as a leader in the medical device sector?